Rating Change
UBS analysts initiated coverage on BioAge Labs, Inc. (NASDAQ:BIOA) with a rating of Neutral on October 12, 2026.
new coverageNASDAQ:BIOA
UBS Initiates Coverage on BioAge Labs, Inc. (BIOA) with Neutral
UBS analysts initiated coverage on BioAge Labs, Inc. (NASDAQ:BIOA) with a rating of Neutral on October 12, 2026.
At publication ·
What changed
BioAge Labs, Inc. (NASDAQ:BIOA) · new coverage
- Firm
- UBS
- Rating
- Neutral
- Price at event
- $5.95
- Market capitalization
- $458.0M
At a glance
Key takeaways
- UBS initiated coverage of BioAge Labs (BIOA) with a Neutral rating on October 12, 2026, while the stock trades at $5.95 with a $458.0M market capitalization.
Market Context
BioAge Labs, Inc. operates in the Healthcare sector. The stock currently trades at $5.95 with a market capitalization of $458.0M.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for BioAge Labs, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for BioAge Labs, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | UBS | Neutral | N/A |
| Sep 09, 2026 | Roth Capital | Buy | N/A |
| Sep 08, 2026 | BTIG | Buy | N/A |
| Aug 06, 2026 | BTIG | Buy | N/A |
| Aug 03, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View BIOA Stock Page
Frequently Asked Questions
What does the Neutral rating mean for BIOA?
A rating of Neutral from UBS reflects the analyst's outlook on BioAge Labs, Inc. (NASDAQ:BIOA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BIOA forecast page.